 "cadila, cadila healthcare, pharma")
Pharmaceutical major Cadila Healthcare reported a 17 per cent year-on-year (YoY) dip in consolidated net profit for the second quarter of this fiscal year to Rs 4.1 billion, as revenue from operations declined 8.1 per cent.
The company posted revenue from operations of Rs 29.61 billion during the quarter under review, compared to Rs 32.22 billion in the corresponding period last fiscal year. Cost of materials consumed increased by 12 per cent YoY to Rs 6.5 billion. Employee costs, too, increased by 13 per cent during the quarter.
At the operating level, Ebitda (earnings before interest, tax, depreciation and amortisation) dipped 20
